| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Quest PharmaTech Inc (V: QPT)
QPT Technical Analysis
5
| As on 31st Mar 2025 QPT STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.05 & Strong Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
QPTSTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.03 | 1 Day | 0.00 | 0.00 |
| Low | 0.02 | 1 Week | 0.00 | 0.00 |
| Close | 0.03 | 1 Month | 0.00 | 0.00 |
| Volume | 370557 | 1 Year | -0.06 | -66.67 |
| 52 Week High 0.10 | 52 Week Low 0.02 | ||||
V Canada Most Active Stocks
| SML | 1435.70 | 0.53% |
| NU | 10.36 | -26.32% |
| GXU | 0.06 | 50.00% |
| FUU | 0.22 | 15.79% |
| CVV | 0.93 | 13.41% |
| SNS | 0.42 | % |
| MJS | 0.09 | 0.00% |
| EU | 2.05 | 7.89% |
| VO | 0.07 | 0.00% |
| SYH | 0.36 | 12.50% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
| QPT Daily Charts |
QPT Intraday Charts |
Whats New @ Bazaartrend |
QPT Free Analysis |
|
|
QPT Important Levels Intraday
| RESISTANCE | 0.05 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| SUPPORT | 0.02 |
| SUPPORT | 0.02 |
| SUPPORT | 0.02 |
| SUPPORT | 0.01 |
QPT Forecast April 2025
| 4th UP Forecast | 0.13 |
| 3rd UP Forecast | 0.1 |
| 2nd UP Forecast | 0.08 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.04 |
| 4th DOWN Forecast | -0.07 |
QPT Weekly Forecast
| 4th UP Forecast | 0.05 |
| 3rd UP Forecast | 0.04 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | 0.01 |
QPT Forecast2025
| 4th UP Forecast | 0.16 |
| 3rd UP Forecast | 0.12 |
| 2nd UP Forecast | 0.09 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.06 |
| 4th DOWN Forecast | -0.1 |
Quest PharmaTech Inc ( V Canada Symbol : QPT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
QPT Business Profile
Quest PharmaTech Inc., a biopharmaceutical company, develops and commercializes antibody based immunotherapeutic products for cancer. Its lead product candidates are Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications; and Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. The company also develops combinatorial immunotherapeutic products for cancer by using monoclonal antibodies of the immunoglobulin G and E class in combination with chemotherapy/immune-adjuvant; and immunotherapy products for pancreatic cancer. In addition, it develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; and skin penetrating active molecules for cosmetic and pharmaceutical use. Quest PharmaTech Inc. is headquartered in Edmonton, Canada. Address: 8123 Roper Road NW, Edmonton, AB, Canada, T6E 6S4
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service